Mylanta Double Strength Tablets

Mylanta Double Strength Tablets is a brand of medicine containing the active ingredients aluminium hydroxide gel, dried - magnesium hydroxide - simethicone.

We do not currently have a consumer medicine information (CMI) leaflet for this brand of medicine.

CMIs are written by the manufacturer and explain how the medicine works and how to take it.

This page about Mylanta Double Strength Tablets automatically lists related information collected from other pages of our website.

The list below includes links to conditions that Mylanta Double Strength Tablets might be used to treat.

Consumers: If you have any questions about medicines, you can speak to one of our pharmacists at NPS Medicines Line by calling 1300 633 424. You can ring Monday to Friday, 9 am to 5 pm, Australian Eastern Standard Time (excluding NSW public holidays). For non-medicine products, further information may also be available from the manufacturer.

Related information - Mylanta Double Strength Tablets


10 Apr 2015 Find reliable independent health and treatment information about heartburn and reflux written by Australian experts. This includes resources for consumers and health professionals.
02 Nov 2012 Find reliable, independent information about hiatus hernia. You’ll find resources for consumers and health professionals about this health condition and any related treatments, medicines and medical tests.
29 Oct 2012 Information on medicines available in Australia containing aluminium hydroxide gel, dried - magnesium hydroxide - simethicone, including our latest evidence-based information and resources for health professionals and consumers. The active ingredient is the chemical in a medicine that makes it work. Medicines that contain the same active ingredient can be available under more than one brand name. Brands include both active ingredients and inactive ingredients. You'll find information about brands of medicines that contain aluminium hydroxide gel, dried - magnesium hydroxide - simethicone below, including their consumer medicine information (CMI) leaflets.